pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 1·1 min read
save

K Health plans IPO by 2029 after recent funding round

Sep 1, 2026·read at Endpoints ↗Positive

K Health, a virtual‑care company that uses AI, announced its intention to go public by 2029.

CEO Allon Bloch made the comment after a recent fundraising round, signalling the firm is preparing for a future IPO.

The plan highlights the growing interest in health‑tech businesses that support patients and clinicians with artificial intelligence, and could draw investor attention as the sector expands.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “K Health is eyeing an IPO by 2029”

read at Endpoints ↗
86 words · retrieved Sep 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Ophthalmology

related stories

  • May 6STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share priceSTAT
  • May 6HHS tackles ‘overmedication’STAT
  • May 6Bayer to buy Perfuse Therapeutics for $300M upfrontEndpoints
  • May 6Opinion: Dr. Glaucomflecken wants to make a stinkSTAT
  • May 5Viridian data lift prospects for thyroid eye disease drugBioPharma Dive